Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-21-019853
Filing Date
2021-06-04
Accepted
2021-06-04 13:52:52
Documents
8
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 6-K brhc10025498_6k.htm 6-K 7781
2 EXHIBIT 99.1 brhc10025498_ex99-1.htm EX-99.1 33919
3 image00001.jpg GRAPHIC 2708
4 image00002.jpg GRAPHIC 3185
5 image00003.jpg GRAPHIC 2987
6 image00004.jpg GRAPHIC 22426
7 image00005.jpg GRAPHIC 14495
8 image00006.jpg GRAPHIC 16119
  Complete submission text file 0001140361-21-019853.txt   128646
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 21995879
SIC: 2834 Pharmaceutical Preparations